Autopsy report · NCT02880410

Feasibility Study on LITT for Newly Diagnosed Glioblastoma

“Terminated (failure to enroll)”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year before it started.
• Ran for about 1 year 1 month before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Monteris Medical

Sponsor type

Industry

Conditions

Glioblastoma

Interventions

NeuroBlate System; Radiation therapy and temozolomide

Participants

3

Sites

4

Countries

United States

Trials that died the same way

• Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy
  “Terminated due to lack of enrollment” (90% match in meaning)
• Polycystic Liver Disease in Kidney Transplant
  “Terminated due to inadequate enrollment” (89% match in meaning)
• Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease
  “terminated due to poor enrollment” (89% match in meaning)
• An Investigator-initiated Study to Evaluate Safety and Efficacy of ARINA-1 in People With a Tracheostomy
  “Terminated due to enrollment challenges” (85% match in meaning)
• Study to Determine the Utility of Wound Vacuum Assisted Closure (VAC) Compared to Conventional Saline Dressing Changes
  “terminated, due to lack enrollment,” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.